Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-04
DOI
10.1038/s41397-021-00209-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacogenomics: An evolving clinical tool for precision medicine
- (2020) Jennifer K. Hockings et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Connecting With Patients—The Missing Links
- (2020) Lisa Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
- (2020) Barnaby Edward Young et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Potential interventions for novel coronavirus in China: A systematic review
- (2020) Lei Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
- (2020) Eva Schrezenmeier et al. Nature Reviews Rheumatology
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Risks of ACE Inhibitor and ARB Usage in COVID‐19: Evaluating the Evidence
- (2020) Krishna Sriram et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection
- (2020) Yin‐Xiao Du et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus
- (2020) Michele Costanzo et al. CURRENT MEDICINAL CHEMISTRY
- Old and re-purposed drugs for the treatment of COVID-19
- (2020) Shio-Shin Jean et al. Expert Review of Anti-Infective Therapy
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
- (2020) Eli S. Rosenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Covid-19 — The Search for Effective Therapy
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19
- (2020) Santosh Kumar et al. Viruses-Basel
- C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism
- (2020) Joris R Delanghe et al. European Journal of Preventive Cardiology
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19)
- (2020) Evellyn Claudia Wietzikoski Lovato et al. CURRENT PHARMACEUTICAL DESIGN
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
- (2020) Jennifer Santos et al. Viruses-Basel
- Naturally Derived Heme-Oxygenase 1 Inducers and Their Therapeutic Application to Immune-Mediated Diseases
- (2020) Samanta C. Funes et al. Frontiers in Immunology
- The complement system in COVID-19: friend and foe?
- (2020) Anuja Java et al. JCI Insight
- Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm
- (2020) Eddie W. Fakhouri et al. Antioxidants
- Targeting the Heme-Heme Oxygenase System to Prevent Severe Complications Following COVID-19 Infections
- (2020) Frank A. D. T. G. Wagener et al. Antioxidants
- Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
- (2020) Jeffrey Laurence et al. CLINICAL IMMUNOLOGY
- PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID‐19
- (2020) Rachel Huddart et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Important Pharmacogenetic Information for Drugs Prescribed During the SARS‐CoV‐2 Infection (COVID‐19)
- (2020) Pablo Zubiaur et al. CTS-Clinical and Translational Science
- Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19
- (2020) Nousheen Bibi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19)
- (2020) Neelu Batra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
- (2020) Donald J. Benton et al. NATURE
- COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
- (2020) Giuseppe Magro VIRUS RESEARCH
- Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19
- (2020) Donato Gemmati et al. Genes
- Pharmacogenomics of COVID-19 therapies
- (2020) Takuto Takahashi et al. npj Genomic Medicine
- Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
- (2020) Sultan Ayoub Meo et al. JOURNAL OF KING SAUD UNIVERSITY SCIENCE
- FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
- (2020) Sylwester Drożdżal et al. DRUG RESISTANCE UPDATES
- Lack of efficacy of Ivermectin for prevention of a lethal Zika virus infection in a murine system
- (2019) Harshada Ketkar et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Clinical Pharmacogenetics Implementation Consortium ( CPIC ) Guideline for CYP 2B6 and Efavirenz‐containing Antiretroviral Therapy
- (2019) Zeruesenay Desta et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later
- (2019) Mary V. Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association of SLC15A1 polymorphisms with susceptibility to dyslipidaemia in a Chinese Han population
- (2019) Shu Liu et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Coronavirus genomic RNA packaging
- (2019) Paul S. Masters VIROLOGY
- Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants
- (2018) Miriam Saiz-Rodríguez et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation
- (2018) Meng Yu et al. CURRENT DRUG METABOLISM
- FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis
- (2018) Alberto Jiménez Morales et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Nrf2-dependent induction of innate host defense via heme oxygenase-1 inhibits Zika virus replication
- (2017) Hanxia Huang et al. VIROLOGY
- Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives
- (2017) Yan-Jiao Zhang et al. International Journal of Environmental Research and Public Health
- Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia
- (2017) Geraldine M Clarke et al. eLife
- Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms
- (2016) Jian Shi et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials
- (2016) Vincent Madelain et al. CLINICAL PHARMACOKINETICS
- Pharmacogenetics: The right drug for you
- (2016) Liam Drew NATURE
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- The effect of SNPs in CYP450 in chloroquine/primaquinePlasmodium vivaxmalaria treatment
- (2016) Vinicius A Sortica et al. PHARMACOGENOMICS
- Influence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis
- (2016) M Maldonado-Montoro et al. PHARMACOGENOMICS JOURNAL
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forUGT1A1and Atazanavir Prescribing
- (2015) RS Gammal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
- (2015) Joanna Dobson et al. LANCET
- PharmGKB summary
- (2015) Ellen M. McDonagh et al. Pharmacogenetics and Genomics
- Common synonymous variants in ABCA4 are protective for chloroquine induced maculopathy (toxic maculopathy)
- (2015) Felix Grassmann et al. BMC Ophthalmology
- Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus
- (2015) Ji Yeon Lee et al. Arthritis & Rheumatology
- Pharmacokinetic Enhancers in HIV Therapeutics
- (2014) Kajal B. Larson et al. CLINICAL PHARMACOKINETICS
- Influence of ABCB1 gene polymorphisms on the pharmacokinetics of azithromycin among healthy Chinese Han ethnic subjects
- (2014) Xiao-Jing He et al. Pharmacological Reports
- Chloroquine cardiomyopathy – a review of the literature
- (2013) Ernst Tönnesmann et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- The Cytoprotective Enzyme Heme Oxygenase-1 Suppresses Ebola Virus Replication
- (2013) L. Hill-Batorski et al. JOURNAL OF VIROLOGY
- Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis
- (2013) Seyed Hamidreza Mahmoudpour et al. PHARMACOGENOMICS
- Carboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans
- (2012) E K Tarkiainen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenomics Knowledge for Personalized Medicine
- (2012) M Whirl-Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants
- (2012) Emily R. Holzinger et al. Pharmacogenetics and Genomics
- Short Communication: UGT1A1*28 Variant Allele Is a Predictor of Severe Hyperbilirubinemia in HIV-Infected Patients on HAART in Southern Brazil
- (2011) Lisiane Turatti et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites
- (2011) Ying-Ying Yang et al. CLINICAL SCIENCE
- Personalizing medicine with clinical pharmacogenetics
- (2011) Stuart A. Scott GENETICS IN MEDICINE
- An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics
- (2011) S J Wolf et al. PHARMACOGENOMICS JOURNAL
- Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy
- (2010) Robert L Murphy et al. AIDS
- Association Between Heme Oxygenase-1 Gene Promoter Polymorphisms and Type 2 Diabetes Mellitus: A HuGE Review and Meta-Analysis
- (2010) Wei Bao et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity
- (2010) F. Vallelian et al. BLOOD
- HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz
- (2009) Zulma G Vitezica et al. AIDS
- Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused by Plasmodium vivax
- (2009) H.-S. Lim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- IL-1β (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome
- (2009) Victor Asensi et al. GENETICS IN MEDICINE
- Effects of the CYP2D6 Gene Duplication on the Pharmacokinetics and Pharmacodynamics of Tramadol
- (2009) Julia Kirchheiner et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy
- (2008) Barbara Zanone Poma et al. AIDS
- Activation of the Antiviral Prodrug Oseltamivir Is Impaired by Two Newly Identified Carboxylesterase 1 Variants
- (2008) H.-J. Zhu et al. DRUG METABOLISM AND DISPOSITION
- Common variants of FUT2 are associated with plasma vitamin B12 levels
- (2008) Aditi Hazra et al. NATURE GENETICS
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ketoconazole increases the plasma levels of ivermectin in sheep
- (2008) Michel Alvinerie et al. VETERINARY PARASITOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started